These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunohistochemical analysis of KBA.62 in 18 neurothekeomas: a potential marker for differentiating neurothekeoma, but a marker that may lead to confusion with melanocytic tumors. Suarez A, High WA. J Cutan Pathol; 2014 Jan; 41(1):36-41. PubMed ID: 24151815 [Abstract] [Full Text] [Related]
7. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma. Gleason BC, Nascimento AF. Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958 [Abstract] [Full Text] [Related]
10. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis. Plaza JA, Bonneau P, Prieto V, Sangueza M, Mackinnon A, Suster D, Bacchi C, Estrozi B, Kazakov D, Kacerovska D, Falconieri G, Suster S. J Cutan Pathol; 2016 Apr; 43(4):313-23. PubMed ID: 26661921 [Abstract] [Full Text] [Related]
15. Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. Erdag G, Chowdhuri SR, Fetsch P, Erickson D, Hughes MS, Filie AC. Diagn Cytopathol; 2013 Oct; 41(10):847-51. PubMed ID: 23554410 [Abstract] [Full Text] [Related]
16. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions. Nielsen PS, Riber-Hansen R, Steiniche T. Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457 [Abstract] [Full Text] [Related]
17. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. Isabel Zhu Y, Fitzpatrick JE. J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409 [Abstract] [Full Text] [Related]
18. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics. Palla B, Su A, Binder S, Dry S. Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581 [Abstract] [Full Text] [Related]
19. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Murali R, Shaw HM, Lai K, McCarthy SW, Quinn MJ, Stretch JR, Thompson JF, Scolyer RA. Cancer; 2010 Sep 01; 116(17):4130-8. PubMed ID: 20564101 [Abstract] [Full Text] [Related]
20. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma. Bolander A, Agnarsdóttir M, Wagenius G, Strömberg S, Pontén F, Ekman S, Brattström D, Larsson A, Einarsson R, Ullenhag G, Hesselius P, Bergqvist M. Melanoma Res; 2008 Dec 01; 18(6):412-9. PubMed ID: 19011512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]